Home > Insider Trading > Filing (0001213900-18-002426)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1587221	Zosano Pharma Corp	ZSAN	()	NV

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1565981	Amzak Capital Management, Llc	980 N Federal Highway Suite 315 Boca Raton FL 33432	No	No	Yes	No
1702234	J Gerald Kazma	980 N Federal Highway Suite 315 Boca Raton FL 33432	No	No	Yes	No
1702237	D Michael Kazma	980 N Federal Highway Suite 315 Boca Raton FL 33432	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value Of $0.0001	Disposition	2018-02-26	1,500	$11.00	256,091	No	4	S	Direct
Common Stock, Par Value Of $0.0001	Disposition	2018-02-27	80,880	$8.36	175,211	No	4	S	Direct
Common Stock, Par Value Of $0.0001	Disposition	2018-02-27	5,901	$8.26	0	No	4	S	Indirect	Owned by Michael D. Kazma, manager of Amzak Capital Management, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Owned by Michael D. Kazma, manager of Amzak Capital Management, LLC

Footnotes

The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.61, inclusive. The Reporting Persons undertake to provide to Zosano Pharma Corp. ("Zosano"), any security holder of Zosano, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (2) and (3) of this Form 4.
These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35, inclusive.